In 2021, Zheng et al. designed a microfluidic chip that could precisely control the concentration of dissolved oxygen and found that under normoxic or hypoxic conditions, the HIF-1α pathway increased EMT and contributed to the metastatic progression of lung cancer to the liver (Zheng et al., 2021). This evidence concerns the gene HIF1A and lung cancer.